| human | Q5 |
| P6178 | Dimensions author ID | 0751300732.20 |
| P1207 | NUKAT ID | n2017001262 |
| P496 | ORCID iD | 0000-0002-7347-7761 |
| P7293 | PLWABN ID | 9810580752005606 |
| P1153 | Scopus author ID | 55637830500 |
| P214 | VIAF ID | 311801684 |
| P69 | educated at | McMaster University | Q632891 |
| University College Cork | Q1574185 | ||
| P108 | employer | McMaster University | Q632891 |
| University of Galway | Q644478 | ||
| Galway University Hospitals | Q101071017 | ||
| P734 | family name | O'Donnell | Q21497115 |
| O'Donnell | Q21497115 | ||
| O'Donnell | Q21497115 | ||
| P735 | given name | Martin | Q18002399 |
| Martin | Q18002399 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q38942192 | A MultiCenter Pilot Randomized Controlled Trial of Remote Ischemic Preconditioning in Major Vascular Surgery |
| Q34533853 | A diagnostic strategy involving a quantitative latex D-dimer assay reliably excludes deep venous thrombosis |
| Q34298526 | A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease |
| Q33834098 | A systematic review of interventions to improve outcomes for young adults with Type 1 diabetes. |
| Q56768969 | Advance preferences regarding thrombolysis in patients at risk for stroke: a cross-sectional study |
| Q38495525 | Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies |
| Q39474127 | Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study |
| Q55232077 | Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial. |
| Q37120116 | Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review |
| Q57243724 | Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation |
| Q35752603 | Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q38390896 | Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis. |
| Q34163710 | Apixaban in patients with atrial fibrillation |
| Q50503138 | Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. |
| Q28194482 | Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin? |
| Q93013202 | Aspirin for primary prevention of stroke in individuals without cardiovascular disease-A meta-analysis |
| Q40321137 | Assessment of Dietary Sodium and Potassium in Canadians Using 24-Hour Urinary Collection |
| Q38116156 | Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants |
| Q34282230 | Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery |
| Q43717513 | Association of atrial fibrillation with mortality and disability after ischemic stroke |
| Q51317433 | Association of urinary sodium and potassium excretion with blood pressure. |
| Q30250220 | Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies |
| Q48696516 | Atrial fibrillation in patients with cryptogenic stroke |
| Q38978991 | Attitudes to outcomes measured in clinical trials of cardiovascular prevention. |
| Q57243771 | Behavioural and Psychological Symptoms in Community-Dwelling Elderly Persons with Cognitive Impairment and Dementia |
| Q34657697 | Beyond unfractionated heparin and warfarin: current and future advances |
| Q47302090 | Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin |
| Q42693620 | COL4A2 is associated with lacunar ischemic stroke and deep ICH: Meta-analyses among 21,500 cases and 40,600 controls |
| Q36889882 | Challenges of establishing new antithrombotic therapies in atrial fibrillation |
| Q52662883 | Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. |
| Q48095680 | Chronic pain syndromes after ischemic stroke: PRoFESS trial |
| Q36981935 | Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study |
| Q60359522 | Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis |
| Q48687138 | Cognitive impairment and risk of cardiovascular events and mortality |
| Q87315032 | Commentary: Accepting what we don't know will lead to progress |
| Q43978668 | Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials |
| Q45081471 | Covert stroke after non-cardiac surgery: a prospective cohort study. |
| Q40359643 | Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. |
| Q38486912 | Dietary sodium and cardiovascular disease |
| Q27860791 | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 |
| Q34053247 | Do all ischemic stroke subtypes benefit from organized inpatient stroke care? |
| Q38243248 | Does lowering blood pressure with antihypertensive therapy preserve independence in activities of daily living? A systematic review |
| Q90622239 | Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline |
| Q28200027 | ESPRIT trial |
| Q35115216 | Early cerebral small vessel disease and brain volume, cognition, and gait |
| Q57243747 | Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease |
| Q33441219 | Effectiveness of a smartphone application to promote physical activity in primary care: the SMART MOVE randomised controlled trial |
| Q91984171 | Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study |
| Q46713985 | Effects of dietary or injected organic cations on larval Drosophila melanogaster: mortality and elimination of tetraethylammonium from the hemolymph |
| Q42781496 | Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial |
| Q38090675 | Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials |
| Q48697496 | Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry |
| Q44447737 | Embolic strokes of undetermined source: the case for a new clinical construct |
| Q57243774 | Emerging therapies for stroke prevention in atrial fibrillation |
| Q44994368 | Escalating levels of access to in-hospital care and stroke mortality |
| Q44809979 | Establishing an optimal therapeutic range for coumarins: filling in the gaps |
| Q40682902 | Estimating average attributable fractions with confidence intervals for cohort and case-control studies. |
| Q48593530 | Estimating treatment effects in observational studies |
| Q53155141 | Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial. |
| Q33423410 | Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis |
| Q38258272 | Evidence relating sodium intake to blood pressure and CVD. |
| Q57243736 | Extreme Sodium Reductions for the Entire Population: Zealotry or Evidence Based? |
| Q35008806 | Fine particulate air pollution (PM2.5) and the risk of acute ischemic stroke |
| Q39314231 | Frontal bodies: Novel structures involved in water vapour absorption by the desert burrowing cockroach, Arenivaga investigata |
| Q57243757 | GASTROINTESTINAL BLEEDING AFTER ACUTE ISCHEMIC STROKE |
| Q44068685 | Gastrointestinal bleeding after acute ischemic stroke |
| Q29417025 | Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies |
| Q39505666 | Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry. |
| Q34272892 | Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 |
| Q27015585 | Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 |
| Q38853757 | Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study |
| Q21534928 | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 |
| Q26782024 | Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q57243753 | Graduated compression stockings to prevent venous thromboembolism in hospital: evidence from patients with acute stroke |
| Q90042587 | Graphical comparisons of relative disease burden across multiple risk factors |
| Q35686176 | Healthy eating and reduced risk of cognitive decline: A cohort from 40 countries |
| Q51103723 | Hospital volume and stroke outcome: does it matter? |
| Q88501887 | How Robust Is the Evidence for Recommending Very Low Salt Intake in Entire Populations? |
| Q57243755 | How generalisable is INTERSTROKE? – Authors' reply |
| Q57243750 | IScore |
| Q41471070 | Impact of language barriers on stroke care and outcomes |
| Q48518076 | In-hospital myocardial infarction following acute ischaemic stroke: an observational study |
| Q40200098 | Incidental magnetic resonance diffusion-weighted imaging-positive lesions are rare in neurologically asymptomatic community-dwelling adults |
| Q35856804 | Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies |
| Q37781101 | Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy |
| Q62486223 | Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study |
| Q38776196 | Leflunomide Use and Risk of Lung Disease in Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis of Randomized Controlled Trials. |
| Q92966113 | Letter by Mente et al Regarding Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease" |
| Q92410980 | Lipid Lowering Therapy, Low-Density Lipoprotein Level and Risk of Intracerebral Hemorrhage - A Meta-Analysis |
| Q89421299 | Low sodium intake and cardiovascular health: an unanswered question. Response to: Letter from Dr N. Campbell, 'Dissidents and dietary sodium. Concerns about the commentary by O'Donnell et al.' |
| Q90181210 | Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin |
| Q43250059 | Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials |
| Q41718601 | Measuring Sodium Intake in Populations: Simple Is Best? |
| Q38849775 | Mendelian Genes and Risk of Intracerebral Hemorrhage and Small-Vessel Ischemic Stroke in Sporadic Cases |
| Q35895157 | Methodology for guideline development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy |
| Q27010623 | Methodology of the global and regional burden of stroke study |
| Q51728375 | Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. |
| Q28085725 | Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials |
| Q38084403 | Mild chronic kidney disease and functional impairment in community-dwelling older adults. |
| Q43666424 | Mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches |
| Q90921242 | Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis |
| Q46960763 | Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes |
| Q57243773 | New anticoagulants |
| Q35001733 | New anticoagulants for atrial fibrillation |
| Q34655477 | New glaucoma medications in the geriatric population: efficacy and safety |
| Q36954143 | Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review |
| Q38154728 | Novel oral anticoagulants: a focused review for stroke physicians |
| Q91759109 | Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial |
| Q57243764 | Perioperative Management of Oral Anticoagulation |
| Q36353366 | Perioperative management of oral anticoagulation |
| Q40929138 | Peripheral Blood MCEMP1 Gene Expression as a Biomarker for Stroke Prognosis |
| Q57243770 | Pexelizumab Does Not “Complement” Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction |
| Q91004367 | Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9 |
| Q40535476 | Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study |
| Q42829950 | Possible influence of stroke etiology on hemorrhagic transformation following thrombolysis in warfarin-treated patients |
| Q56912168 | Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study |
| Q36792002 | Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy |
| Q57243772 | Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study |
| Q35552969 | Preconditioning Shields Against Vascular Events in Surgery (SAVES), a multicentre feasibility trial of preconditioning against adverse events in major vascular surgery: study protocol for a randomised control trial |
| Q37462060 | Prevalence of cardiovascular risk factors in the Middle East: a systematic review |
| Q39626752 | Preventing cardiovascular disease in primary care: role of a national risk factor management program |
| Q50326444 | Prevention, management, and rehabilitation of stroke in low- and middle-income countries |
| Q92696443 | Promoting Independent Mobility-related Physical ACTivity (IMPACT) in an inpatient stroke rehabilitation unit: a proof-of-concept evaluation of self-management intervention |
| Q28293377 | Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study |
| Q53393952 | Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients. |
| Q38008937 | Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation |
| Q43138653 | Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment |
| Q43100812 | Rationale and design of INTERSTROKE: a global case-control study of risk factors for stroke |
| Q47683660 | Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial |
| Q57628374 | Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial |
| Q31145108 | Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review |
| Q33606522 | Reliability of proxy respondents for patients with stroke: a systematic review |
| Q57243732 | Reply |
| Q51313140 | Reply to both letters. |
| Q89421459 | Response by Smyth et al to Letters Regarding Article, "Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction: The INTERHEART Study" |
| Q87883121 | Response to: 'More on dissidents and dietary sodium' |
| Q43012682 | Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study |
| Q44454058 | Risk factors for posterior compared to anterior ischemic stroke: an observational study of the Registry of the Canadian Stroke Network |
| Q43934356 | Risk factors for stroke in Tanzania |
| Q60918058 | Risk of bias assessment of sequence generation: a study of 100 systematic reviews of trials |
| Q47389765 | Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal |
| Q53211735 | Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials. |
| Q56968635 | Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source |
| Q57312989 | Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial |
| Q53098804 | Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. |
| Q47408050 | Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial |
| Q46938524 | Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial |
| Q92455767 | Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin |
| Q51838214 | Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trial. |
| Q37063678 | Sexual counselling for patients with cardiovascular disease: protocol for a pilot study of the CHARMS sexual counselling intervention. |
| Q57243754 | Should Patients With Stroke Wear Compression Stockings to Prevent Venous Thromboembolism? |
| Q40251810 | Sleep to Lower Elevated Blood Pressure: A Randomized Controlled Trial (SLEPT). |
| Q28654412 | Sleep to lower elevated blood pressure: study protocol for a randomized controlled trial |
| Q57243726 | Sodium and Cardiovascular Disease |
| Q88976124 | Sodium and cardiovascular disease - Authors' reply |
| Q27014682 | Sodium intake and cardiovascular health |
| Q38186600 | Sodium intake and renal outcomes: a systematic review |
| Q91153650 | Stroke Outcomes in the COMPASS Trial |
| Q47918092 | Subclinical anaemia of chronic disease in adult patients with cystic fibrosis |
| Q37431678 | Supporting the improvement and management of prescribing for urinary tract infections (SIMPle): protocol for a cluster randomized trial |
| Q38417885 | Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk |
| Q57243760 | Tackling the global burden of stroke: the need for large-scale international studies |
| Q55516957 | The CHARMS pilot study: a multi-method assessment of the feasibility of a sexual counselling implementation intervention in cardiac rehabilitation in Ireland. |
| Q89940219 | The INTERSTROKE study on risk factors for stroke - Authors' reply |
| Q44208457 | The PLAN score: a bedside prediction rule for death and severe disability following acute ischemic stroke |
| Q57243733 | The Population Risks of Dietary Salt Excess Are Exaggerated |
| Q57243777 | The Self-Perceived Role and Educational Needs of Pharmaceutical Representatives: A Survey |
| Q30205749 | The burden of disease in older people and implications for health policy and practice |
| Q30974886 | The effect of renal sympathetic denervation on nocturnal dipping in patients with resistant hypertension; observational data from a tertiary referral centre in the Republic of Ireland. |
| Q39157314 | The mini-mental state examination, clinical factors, and motor vehicle crash risk |
| Q43663366 | The prevalence of aortic calcification on vertebral fracture assessment imaging among patients with rheumatoid arthritis |
| Q44793969 | The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis |
| Q56058871 | The relationship between estimated sodium and potassium excretion and subsequent renal outcomes |
| Q57243769 | Thromboembolism prevention in ischaemic stroke |
| Q48371101 | Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke |
| Q38273906 | Transesophageal echocardiography in patients with cryptogenic ischemic stroke: a systematic review |
| Q30380729 | Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study |
| Q46714861 | Urinary sodium and potassium excretion and risk of cardiovascular events |
| Q50645400 | Urinary sodium and potassium excretion, mortality, and cardiovascular events. |
| Q92780186 | Urinary sodium excretion measures and health outcomes - Authors' reply |
| Q57928095 | Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study |
| Q46397949 | Using aspirin to prevent cognitive decline |
| Q51326459 | Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. |
| Q57243779 | Validity of Self-Reports in Dementia Research |
| Q43860714 | Validity of composite outcomes in meta-analyses of stroke prevention trials: the case of aspirin |
| Q57243763 | Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke |
| Q57243721 | Vascular risk factors, cardiovascular disease and functional impairment in community-dwelling adults |
| Q57243781 | Venous thromboembolism after long flights: are airlines to blame? |
| Q51146654 | Vertebral fracture assessment-detected abdominal aortic calcification and cardiovascular disease in rheumatoid arthritis. |
| Q57243722 | Vitamin D supplementation-clarity required regarding treatment regimens and target plasma levels |
| Q35279179 | When it matters that a 'Stroke' is not a stroke |
| Q42649460 | Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation? |
| Q28111913 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 |
Search more.